Bio-Rad Laboratories Class B (BIO.B)
Bio-Rad Laboratories Class B is the common stock of Bio-Rad Laboratories, Inc., a healthcare company focused on life science research and clinical diagnostics. The company develops, manufactures, and distributes products used in research, biopharmaceutical production, quality control, food safety, science education, and clinical testing. Its operations are organized into two segments: Life Science, which provides instruments, systems, reagents, and consumables for separating, purifying, characterizing, and measuring biological materials, and Clinical Diagnostics, which supplies diagnostic test systems, informatics tools, test kits, quality controls, and related software for laboratory and physician office settings. Bio-Rad serves customers across the United States and internationally through direct sales and distribution partners. Founded in 1952, the company is headquartered in Hercules, California.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NYSE-BIO.B
|
$410.22
|
8.7% Upside
|
Fair
|
Not available
|
Not available
|
Good
|
0.0%
|
February 18, 2027
|
9.8x
|
1.3x
|
3.9x
|
10.062 B
|
3.489 B
|
12.3%
|
80.0%
|
3.6
|
32.2%
|